参考文献/References:
[1] Kato S,Chmielewski M,Honda H,et al.Aspects of immune dysfune-tion in end-stage renal disease [J].Clin J Am Soc Nephrol,2008,3(5):1526-1533.
[2] Matthias S,Angele L,Lorenz U,et al.End-stage renal disease,dialysis,kidney transplantation and their impact on CD4+ T-cell differentiation immunology [J].Medicine,2018,155(2):211-224.
[3] Kristin M,Andreas B,Hans MH,et al.Immunological alterations due to hemodialysis might interfere with early complications in renal transplantation [J].Anal Cell Pathol,2019,25(3):1-11.
[4] 聂金霞,陈 难,邓克红.当归补血汤对宫颈癌荷瘤小鼠抑瘤效果及对免疫调节作用的研究[J].陕西中医,2019,40(3):279-282.
[5] 严晓华,闰鲜鹏.玉屏风散颗粒对儿童肾病综合征免疫调节作用的研究[J].陕西中医,2015,36(10):1311-1312.
[6] Didier D,Mathieu L,Jamal B,et al.ESRD-associated immune phenotype depends on dialysis modality and iron status:clinical implications [J].Immun Ageing,2018,15(1):16.
[7] Katarzyna A,Lisowska B,Maigorzata P,et al.The influence of a single hemodialysis procedure on human T lymphocytes[J].Sci Rep,2019,9(1):5041.
[8] Roshan P,George A,Aneesh KM,et al.Premature T cell senescence in pediatric CKD [J].Jam Soc Nephrol,2017,28(1):359-367.
[9] Li YY,Liu XY,Wang W,et al.Low-dose IL-2 expands CD4+ regulatory T cells with a suppressive function in vitro via the STAT5-dependent pathway in patients with chronic kidney diseases [J].Ren Fail,2018,40(1):280-288.
[10] Danyelle R,Alves R,Melina B,et al.Cytokine signature in end-stage renal disease patients on hemodialysis [J].Dis Markers,2017,6(27):1-9.
[11] 郑 栓,万红波,郑建国,等.健脾补肾活血泄浊方联合杂合式血液净化疗法对慢性肾衰竭患者肾功能及血清CD4+/CD8+水平的影响[J].陕西中医,2019,40(2):188-191.
[12] 梁 敏,欧阳勇.健脾益肾养阴辅助血液透析法对终末期糖尿病肾病细胞免疫功能的影响[J].现代医院,2018,18(12):1854-1858.
[13] 郑 娜,安 智,刘华刚.尿毒清颗粒联合组合型人工肾对糖尿病肾病维持性血液透析患者血脂代谢、炎症反应和细胞免疫功能的影响[J].现代中西医结合杂志,2019,28(20):2208-2211.
[14] 赵榕慧,顾瑛媛,张 霞,等.黄芪皂苷Ⅱ调控CD45分子介导CD4细胞活化效应的研究[J].国际中医中药杂志,2019,41(5):481-486.
[15] 苏保洲.灵芝的现代临床应用探索[J].现代中西医结合杂志,2019,28(5):567-570.
[16] 尹乐乐,叶莎莎,欧阳东云,等.红景天苷对小鼠原代T淋巴细胞体外行为的影响[J].中国病理生理杂志,2018,34(8):1447-1485.